BDX teams up with the Penn Institute for Immunology and Immune Health to launch a high-parameter immune profiling study.

In the 21st century, technology has transformed every aspect of life – from smartphones connecting the world, to social media ...

IGIB, has launched India's first Centre of Excellence for Single-Cell Multiomics to enhance research in immunity, cancer, and ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a strategic ...

The most-read coverage of the latest updates in acute myeloid leukemia (AML) for 2025 focused on the evolution of targeted therapies, the promise of off-the-shelf chimeric antigen receptor (CAR) ...

Urbanization and a warmer climate means that more people want to swim in canals, harbors, and urban beaches. However, this means that they may be swimming close to where treated wastewater and ...

BD Biosciences and CSIR- IGIB inaugurate its first centre of excellence for single-cell multiomics: Our Bureau, Mumbai Tuesday, December 23, 2025, 17:45 Hrs [IST] BD Life Sciences ...

At ELRIG 2025 in Stevenage, AstraZeneca’s Global Leader for Flow Cytometry, Dr Raffaello Cimbro, outlined how imaging flow cytometry has evolved from a specialist tool into a cornerstone ...

BostonGene has won four awards in the Research & Development, Product Launches, and Innovation categories in the 2025 Pharmaceutical Technology Excellence Awards.

Global Hematology Market OverviewThe global hematology market is projected to grow at a CAGR of approximately 3–5% through ...

Standard BioTools has a very small Wall Street following as can be seen above. On average, they expect the company to lose $0 ...